Drawing for AZYMAB

USPTO serial 86009222

AZYMAB

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LAM, HAI-LY HUYNH
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AZYMAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rochelle D. Alpert

ROCHELLE D. ALPERT MORGAN, LEWIS & BOCKIUS LLP1 MARKET SPEAR STREET TOWERSAN FRANCISCO, CA 94105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Therapeutic, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseasesACTIVE—
042Scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment and prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, autoimmune diseases, inflammatory diseases, and infectious diseasesACTIVE—
045Licensing of proprietary intellectual propertyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 9, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 9, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 13, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 13, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 13, 2019CNSISUSPENSION INQUIRY WRITTEN—
Mar 12, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 31, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 31, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Aug 31, 2018CNSLSUSPENSION LETTER WRITTEN—
Aug 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 20, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 6, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 28, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 28, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 28, 2018CNSISUSPENSION INQUIRY WRITTEN—
Feb 26, 2018RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 15, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 15, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Aug 15, 2017CNSLSUSPENSION LETTER WRITTEN—
Aug 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2017ALIEASSIGNED TO LIE—
Jun 26, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 31, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 31, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 31, 2016CNSISUSPENSION INQUIRY WRITTEN—
Dec 29, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 29, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 29, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Jun 29, 2016CNSLSUSPENSION LETTER WRITTEN—
Jun 17, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 18, 2015GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 18, 2015GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 18, 2015CNSISUSPENSION INQUIRY WRITTEN—
Dec 17, 2015RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 12, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 12, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Jun 12, 2015CNSLSUSPENSION LETTER WRITTEN—
May 27, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 27, 2014GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 27, 2014GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 27, 2014CNSISUSPENSION INQUIRY WRITTEN—
Nov 21, 2014RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 21, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 21, 2014GNSLLETTER OF SUSPENSION E-MAILED—
May 21, 2014CNSLSUSPENSION LETTER WRITTEN—
May 21, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 21, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 13, 2014ALIEASSIGNED TO LIE—
Apr 28, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 29, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2013DOCKASSIGNED TO EXAMINER—
Jul 20, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance